Get A$10 trading credit to start you off
Sign up and fund a new Stake AUS account and get A$10 bonus trading credit.Sign up and fund a new Stake AUS account and enjoy an extra A$10 trading credit on us.T&Cs apply
Sign up and fund a new Stake AUS account and get A$10 bonus trading credit.Sign up and fund a new Stake AUS account and enjoy an extra A$10 trading credit on us.T&Cs apply
Mesoblast Limited (MSB) is a Company that is engaged in developing allogeneic (off-the-shelf) cellular medicines for the treatment of inflammatory conditions. The therapies from the Company's proprietary mesenchymal lineage cell therapy technology platform respond to inflammation by releasing anti-inflammatory factors that counter and modulate multiple effector arms of the immune system, resulting in reduction of the damaging inflammatory process.
Find out what a historical investment in Mesoblast would be worth today using our MSB stock calculator.
Market Capitalisation
$2.52B
Price-earnings ratio
-15.25
Dividend yield
-
High today
$2.00
Low today
$1.95
Open price
$2.00
52-week high
$3.31
52-week low
$1.53
Ready to start your investing journey with Stake?
Open an accountThis is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.

Invest in MSB on Stake
Stock shown for demonstrative purposes only. A$3 brokerage up to A$30,000.
MSB related stocks